Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
The association between ZSWIM6 and acromelic frontonasal dysostosis is supported by multiple independent studies demonstrating a recurrent genetic etiology. Initial reports identified a heterozygous de novo missense variant, with subsequent work confirming its presence in several unrelated probands, thereby establishing a robust link between ZSWIM6 mutation and the characteristic craniofacial and limb malformations of the disorder (PMID:26706854). This body of evidence has expanded the phenotypic spectrum and underscored the clinical relevance of the gene in developmental anomalies.
Patients present with a consistent range of malformations, including frontonasal dysplasia, limb abnormalities, and, in some cases, neurological deficits. The phenotypic spectrum further encompasses findings such as agenesis of the corpus callosum, intellectual disability, and preaxial foot polydactyly (PMID:25105228). Such a diverse clinical presentation mandates a thorough genetic evaluation to inform both diagnosis and genetic counseling, especially given the evidence of mosaicism in affected families.
The genetic evidence is marked by the recurrent identification of the c.3487C>T (p.Arg1163Trp) variant in independent cohorts. In one study, the variant was initially identified in four unrelated cases and later in four additional affected individuals from three families, illustrating both de novo occurrence and segregation through mosaicism (PMID:26706854). Another independent study confirmed the de novo status of this variant in a trio and an additional isolated proband, while a separate report implicated a recurrent nonsense variant, c.2737C>T (p.Arg913Ter), in cases lacking the classic frontonasal or limb malformations (PMID:29198722).
Evidence from case reports and series indicates that at least 19 unrelated probands have been identified with pathogenic variants in ZSWIM6. This robust genetic evidence, enhanced by the observation of familial segregation in a mosaic case, underpins the strong genetic association assigned to this gene–disease pair. The recurrent nature of the identified variants across different cohorts further reinforces the causative role of ZSWIM6 in acromelic frontonasal dysostosis (PMID:25105228).
Functional studies have elucidated the pathogenic mechanism underlying the disorder by demonstrating expression of ZSWIM6 in relevant developmental tissues using in situ hybridization in zebrafish embryos and immunohistochemistry in mouse models. Complementary qRT-PCR analyses in patient-derived osteoblast and fibroblast cell lines point to Hedgehog pathway activation as a potential downstream effect of the mutation. These findings, consistent with a dominant-negative or gain-of-function mechanism, provide moderate experimental support that aligns with and reinforces the genetic data (PMID:25105228; PMID:29198722).
The integration of genetic and experimental evidence clearly demonstrates that ZSWIM6 mutations lead to acromelic frontonasal dysostosis via a mechanism that likely disrupts normal developmental signaling. Although the cumulative evidence exceeds the ClinGen scoring maximum, the data are sufficiently cohesive to support strong clinical validity. This integrated overview aids diagnostic decision‑making, informs genetic counseling, and supports potential avenues for targeted therapies.
Key Take‑home sentence: The strong genetic and functional evidence linking recurrent de novo ZSWIM6 mutations with acromelic frontonasal dysostosis establishes its clinical utility as a diagnostic marker in affected individuals.
Gene–Disease AssociationStrongNineteen unrelated probands across independent studies with de novo mutations and mosaic segregation evidence support a strong gene–disease association (PMID:26706854). Genetic EvidenceStrongRecurrent identification of the missense variant c.3487C>T (p.Arg1163Trp) alongside a nonsense variant c.2737C>T (p.Arg913Ter) in 19 probands, including segregation in a mosaic case, provides compelling genetic evidence (PMID:25105228). Functional EvidenceModerateFunctional assays demonstrating tissue-specific expression, Hedgehog pathway activation, and animal model studies supporting a dominant-negative or gain-of-function mechanism lend moderate experimental support (PMID:25105228; PMID:29198722). |